Neuren Pharmaceuticals | NEU - Cost Of Sales

Stock Price
13.05
Daily Change
-0.39 -2.90%
Monthly
-23.68%
Yearly
-1.36%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD7.45M in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 8.13M 2.41M Mar/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.47M 1.19M Jun/2025
Clinuvel Pharmaceuticals AUD 1.93M 4.97M Jun/2024
Genetic Signatures AUD 2.31M 2.32M Jun/2025
Ionis Pharmaceuticals USD 8M 5.66M Dec/2025
Medical Developments International AUD 2.18M 3.09M Jun/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organon & Co USD 745M 25M Sep/2025
Paradigm Biopharmaceuticals AUD 1.88K 16.84K Jun/2025
Starpharma Holdings AUD 876K 528K Jun/2025
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025
Viatris USD 2.56B 167.3M Dec/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025